SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-021053
Filing Date
2020-08-10
Accepted
2020-08-10 08:40:57
Documents
20
Period of Report
2020-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea125186-8k_intecpharma.htm   iXBRL 8-K 30408
2 FORM OF PRE-FUNDED WARRANT ea125186ex4-1_intecpharma.htm EX-4.1 79208
3 OPINION OF MEITAR | LAW OFFICES ea125186ex5-1_intecpharma.htm EX-5.1 10643
4 OPINION OF MCDERMOTT WILL & EMERY LLP ea125186ex5-2_intecpharma.htm EX-5.2 13029
5 SECURITIES PURCHASE AGREEMENT, DATED AUGUST 7, 2020, BETWEEN INTEC PHARMA LTD. A ea125186ex10-1_intecpharma.htm EX-10.1 74632
6 PRESS RELEASE DATED AUGUST 7, 2020 ea125186ex99-1_intecpharma.htm EX-99.1 10808
11 GRAPHIC ex5-1_001.jpg GRAPHIC 27458
12 GRAPHIC image_001.jpg GRAPHIC 4526
  Complete submission text file 0001213900-20-021053.txt   463310

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ntec-20200807.xsd EX-101.SCH 3442
8 XBRL DEFINITION FILE ntec-20200807_def.xml EX-101.DEF 11083
9 XBRL LABEL FILE ntec-20200807_lab.xml EX-101.LAB 22423
10 XBRL PRESENTATION FILE ntec-20200807_pre.xml EX-101.PRE 11486
13 EXTRACTED XBRL INSTANCE DOCUMENT ea125186-8k_intecpharma_htm.xml XML 2554
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 201087280
SIC: 2834 Pharmaceutical Preparations